merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The court ruling creates a shadow on von der Leyen's leadership and could potentially make her upcoming vote for a second term more challenging, as she will need to rely on a broad coalition and secure 361 votes in a tight vote</answer>

<question_number>2</question_number>
<answer>The article suggests that the lack of transparency in vaccine contracts has contributed to a sense of distrust among European voters about how officials spent taxpayer money, which may have indirectly fueled support for far-right politicians</answer>

<question_number>3</question_number>
<answer>The article indicates that von der Leyen will need votes from center-left lawmakers including the Greens, who have been "incensed by the way she handled the coronavirus crisis"</answer>

<question_number>4</question_number>
<answer>The article implies that the European Commission's lack of transparency in vaccine contracts has contributed to voter distrust, potentially creating an environment more receptive to far-right politicians</answer>

<question_number>5</question_number>
<answer>The court ruling highlights transparency issues in vaccine contracts, which the article suggests has contributed to growing voter distrust amid the rise of far-right politicians</answer>

<question_number>6</question_number>
<answer>The timing of the court ruling just before the vote on her future could potentially undermine her credibility and make her confirmation more difficult</answer>

<question_number>7</question_number>
<answer>Initially conservative and budget-conscious in vaccine procurement, the EU later secured a massive Pfizer-BioNTech contract worth billions and even surpassed other countries in vaccination, but then faced criticism about ordering too many vaccines</answer>

<question_number>8</question_number>
<answer>The Commission claims it needed to balance public access with contract requirements, yet the court found it wrongly withheld information and did not demonstrate how wider access would undermine commercial interests</answer>

<question_number>9</question_number>
<answer>Both cases involve transparency, with the court ruling supporting the principle of freedom of information that The New York Times is pursuing in its pending lawsuit about text messages between von der Leyen and Pfizer's CEO</answer>

<question_number>10</question_number>
<answer>The court ruling exposes transparency issues in the EU's pandemic response, potentially reinforcing public skepticism about official decision-making during the crisis</answer>